Mobile

A Multicenter, Open-Label Study of Hectorol (doxercalciferol capsules) for the Treatment of Secondary Hyperparathyroidism in Stage 3 or Stage 4 Chronic Kidney Disease (CKD) Patients

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-001043-22

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the safety and tolerability of Hectorol Capsules during 52 weeks of treatment in patients with Stage 3 or Stage 4 CKD

Critère d'inclusion

  • Secondary hyperparathyroidism in Stage 3 or Stage 4 Chronic Kidney Disease

Liens